First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

BACKGROUND. The Breast DX Italy prospective study evaluated the impact of the 21‐gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer. MATERIALS AND METHODS. Nine centers (two Hub and seven Spoke centers of the Veneto Oncology Network) participated....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Dieci, Maria Vittoria, Guarneri, Valentina, Giarratano, Tommaso, Mion, Marta, Tortora, Giampaolo, De Rossi, Costanza, Gori, Stefania, Oliani, Cristina, Merlini, Laura, Pasini, Felice, Bonciarelli, Giorgio, Griguolo, Gaia, Orvieto, Enrico, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2017
Schlagworte:
Breast Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905682/
https://ncbi.nlm.nih.gov/pubmed/29133514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0322
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge